Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12620001097932
Ethics application status
Approved
Date submitted
29/08/2020
Date registered
21/10/2020
Date last updated
21/10/2020
Date data sharing statement initially provided
21/10/2020
Type of registration
Prospectively registered
Titles & IDs
Public title
Quality of life for patients with long term anaemia self-managing red cell transfusions
Query!
Scientific title
A mixed-methods pilot feasibility study of self-managing red cell transfusion requirements in chronic anaemia
Query!
Secondary ID [1]
302178
0
None
Query!
Universal Trial Number (UTN)
U1111-1257-6171
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
chronic anaemia
318845
0
Query!
Condition category
Condition code
Blood
316848
316848
0
0
Query!
Anaemia
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
People with chronic anaemia requiring transfusion will be asked to determine when they feel the need for red cell transfusions based on their symptoms alone, which will be undertaken. Haemoglobin concentrations will be measured, but participants will be asked to decide when they need a transfusion blinded to these results. Transfusion of a unit of blood will occur daily until symptoms are controlled initially, with subsequent red cell dosing based on the haemoglobin level that led to symptom control with the first transfusion. Participants will be asked to undertake quality of life surveys, and interview and wear an activity and pulse tracker each day, as well as undertake a short submaximal exercise test (6 minute walk test) prior and after the first and third transfusions.The study will continue for 6 months.
Query!
Intervention code [1]
318480
0
Treatment: Other
Query!
Comparator / control treatment
No control group.
Query!
Control group
Uncontrolled
Query!
Outcomes
Primary outcome [1]
324960
0
Quality of life as measured by change in FACT-Anaemia score
Query!
Assessment method [1]
324960
0
Query!
Timepoint [1]
324960
0
Prior to third transfusion episode
Query!
Secondary outcome [1]
386340
0
The ability of the participant self-determined need for transfusion to detect an improvement in fatigue levels following transfusion as measured on a linear analogue scale
Query!
Assessment method [1]
386340
0
Query!
Timepoint [1]
386340
0
One day post each transfusion
Query!
Secondary outcome [2]
386341
0
Whole blood haemoglobin values.
Query!
Assessment method [2]
386341
0
Query!
Timepoint [2]
386341
0
Prior to each transfusion
Query!
Secondary outcome [3]
386342
0
Total number of transfusions received during the study period.
Query!
Assessment method [3]
386342
0
Query!
Timepoint [3]
386342
0
During 6 months of study from the time of the first transfusion on study until completion of the study 6 months later.
Query!
Secondary outcome [4]
386343
0
Intervals between transfusions
Query!
Assessment method [4]
386343
0
Query!
Timepoint [4]
386343
0
During 6 months of study from the time of the first transfusion on study until completion of the study 6 months later.
Query!
Secondary outcome [5]
386344
0
Activity (steps/day as counted by the participant worn activity tracker)
Query!
Assessment method [5]
386344
0
Query!
Timepoint [5]
386344
0
in the 4 days before and 4 days after transfusion
Query!
Secondary outcome [6]
386345
0
Resting pulse rate using participant worn activity tracker
Query!
Assessment method [6]
386345
0
Query!
Timepoint [6]
386345
0
In the 4 days before and 4 days after transfusion
Query!
Secondary outcome [7]
386346
0
Visual analogue score for fatigue
Query!
Assessment method [7]
386346
0
Query!
Timepoint [7]
386346
0
Pre transfusion and day 4 post each transfusion
Query!
Secondary outcome [8]
386347
0
Participant acceptability of protocol as determined by semi-structured interview.
Query!
Assessment method [8]
386347
0
Query!
Timepoint [8]
386347
0
At the completion of the study, expected to be 6 months following the first transfusion, unless stopped earlier by patient, investigator or treating clincian.
Query!
Secondary outcome [9]
387356
0
Change in submaximal exercise performance using distance walked in 6 minute walk test.
Query!
Assessment method [9]
387356
0
Query!
Timepoint [9]
387356
0
Immediately prior to the first and third transfusion episodes
Query!
Eligibility
Key inclusion criteria
1. Be 18 years of age or older;
2. Have a benign or malignant haematological disorder requiring recurrent transfusions predominantly in an outpatient setting;
3. Have an expected ongoing need for transfusion over at least the next three months;
4. Have provided fully informed consent to the study, or have declined to participate in the full study, but have provided consent for a single interview on their reasons for non-participation.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
1. Lacking capacity to provide informed consent;
2. Have not provided consent to any aspect of the study;
3. Have transfusions for the treatment of sickle cell disease or thalassaemia;
4. Unable to speak or read English (FACT-An and interviews are in English)
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Non-randomised trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Single group
Query!
Other design features
Query!
Phase
Phase 4
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Paired T tests for the primary outcome and secondary outcomes pre and post transfusion. Descriptive stastistics for health diary reported events and themes from semi-structured interviews
Query!
Recruitment
Recruitment status
Not yet recruiting
Query!
Date of first participant enrolment
Anticipated
3/11/2020
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
7/02/2022
Query!
Actual
Query!
Date of last data collection
Anticipated
30/09/2022
Query!
Actual
Query!
Sample size
Target
15
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
ACT
Query!
Recruitment hospital [1]
17370
0
The Canberra Hospital - Garran
Query!
Recruitment postcode(s) [1]
31099
0
2605 - Garran
Query!
Funding & Sponsors
Funding source category [1]
306601
0
Government body
Query!
Name [1]
306601
0
National Blood Authority
Query!
Address [1]
306601
0
2/243 Northbourne Ave
Lyneham ACT 2602
Query!
Country [1]
306601
0
Australia
Query!
Primary sponsor type
University
Query!
Name
Australian National University
Query!
Address
Garran Road
ACTON ACT 2601
Query!
Country
Australia
Query!
Secondary sponsor category [1]
307133
0
None
Query!
Name [1]
307133
0
Query!
Address [1]
307133
0
Query!
Country [1]
307133
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
306786
0
ACT Health Human Research Ethics Commitee
Query!
Ethics committee address [1]
306786
0
PO Box 11 WODEN ACT 2606
Query!
Ethics committee country [1]
306786
0
Australia
Query!
Date submitted for ethics approval [1]
306786
0
06/01/2020
Query!
Approval date [1]
306786
0
27/08/2020
Query!
Ethics approval number [1]
306786
0
2020.ETH.00011
Query!
Summary
Brief summary
The study will evaluate the feasibility of a patient self-directed transfusion strategy, which it is expected will tailor the benefit to individual needs. People with anaemia on chronic transfusion regimens will be recruited. After a baseline assessment and education, they will have their regular transfusion as prescribed by their doctor and assessments repeated. They will then keep a symptom diary, and when they feel they need a transfusion, asked to contact the study team who will arrange daily red cell transfusions until the recipient feels that they have satisfactorily controlled their symptoms, or where they feel there has been no improvement with additional transfusions. The study will evaluate quality of life, exercise tolerance before and after transfusion, the haemoglobin at which patients choose to have transfusions and feel that they have reached their maximum benefit. There will also be patient interviews at the end of the study to assess acceptability of the self-directed approach.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
105018
0
Dr Philip Crispin
Query!
Address
105018
0
Haematology Department
Canberra Hospital
Yamba Drive
Garran ACT 2605
Query!
Country
105018
0
Australia
Query!
Phone
105018
0
+61251243964
Query!
Fax
105018
0
Query!
Email
105018
0
[email protected]
Query!
Contact person for public queries
Name
105019
0
Philip Crispin
Query!
Address
105019
0
Haematology Department
Canberra Hospital
Yamba Drive
Garran ACT 2605
Query!
Country
105019
0
Australia
Query!
Phone
105019
0
+61 251243964
Query!
Fax
105019
0
Query!
Email
105019
0
[email protected]
Query!
Contact person for scientific queries
Name
105020
0
Philip Crispin
Query!
Address
105020
0
Haematology Department
Canberra Hospital
Yamba Drive
Garran ACT 2605
Query!
Country
105020
0
Australia
Query!
Phone
105020
0
+61251243964
Query!
Fax
105020
0
Query!
Email
105020
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
Few patients at single centre may compromise privacy
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF